Vitasoy International (0345) H2 2013 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2013 earnings summary
23 Oct, 2026Executive summary
FY2012/13 delivered broad-based sales and profit growth across markets and product categories despite slowing economic conditions and rising labor and production costs.
Growth priorities included strengthening brands and distribution, product innovation, and improving manufacturing efficiency.
Financial highlights
Turnover rose 9% YoY to HKD 4.1bn, with growth across all operating markets in volume and value.
Gross profit increased 9% to HKD 1.9bn; profit before taxation rose 4% to HKD 426m.
EBITDA increased 12% to HKD 620m; EBIT rose 5% to HKD 445m; profit attributable to equity shareholders grew 8% to HKD 303m.
Basic EPS rose 8% to HKD 0.296.
Outlook and guidance
FY2013/14 expected to be challenging amid evolving global financial conditions and inflationary pressure on commodity and labor costs.
Priorities include cautious pricing, productivity and cost management, product innovation, stronger distribution, and continued market expansion.
In the U.S., normalized production was expected to support an improved profit position in the coming year.
Latest events from Vitasoy International
- FX-adjusted growth continued, led by China, while Australian drought pressures persist into H2.0345
H1 2020 - Disruptions cut FY profit, while market-share gains and gradual recovery underpin the outlook.0345
H2 2020 - FY18 sales rose 21%, led by China; FY19 growth is expected to moderate.0345
H2 2018 - Underlying sales grew 6% as China led growth, offset by divestiture and rising input costs.0345
H2 2017 - Growth accelerated, but investment and tougher markets shifted focus to sustainable expansion.0345
H2 2016 - Profit rose 18% on asset disposal gain despite 3% revenue drop, with higher dividend and share buy-back.0345
H2 2026 - Revenue down 6% but profit, margins, and dividend held steady amid market challenges.0345
H1 2026 - Operating profit surged 50% and interim dividend rose to HK4.0 cents per share.0345
H1 2025 - FY24 profit surged as Mainland China and Hong Kong led recovery; Australia supply issues persisted.0345
H2 2024